Last reviewed · How we verify
NCT05981898
Opt-IVF Multi-center Trial 2 Including All Protocols
NA trial testing OPTIVF dosage in IVF in 550 participants. Completed in 15 April 2024.
15 March 2024
Quick facts
| Lead sponsor | Stochastic Research Technologies LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 550 |
| Start date | 15 September 2023 |
| Primary completion | 15 March 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across India |
Drugs / interventions tested
- OPTIVF dosage
- traditional Dosage
Conditions studied
- IVF — all drugs for IVF →
Sponsor
Stochastic Research Technologies LLC
Who can join
Adults 18 to 50, female only, with IVF. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multi-center randomized clinical trial is proposed to study the effectiveness of the advanced decision support tool Opt-IVF for ALL PROTOCOLS in reducing medication, testing, and improving outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A multicenter randomized clinical trial with a novel decision support tool to improve IVF success
Diwekar U, Bhoi N, Gupta S, Sharma A, et al · · 2025
Verify or expand the search:
- PubMed search for NCT05981898
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OPTIVF dosage
Trials testing the same drug.
- NCT05811065 — Decision Support Tool for Gonadotrophin Dose Selection in ART. · NA · completed
Other recruiting trials for IVF
Currently open trials in the same condition.
- NCT07364526 — Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients · recruiting
- NCT07088640 — Single Step Protocol and Multi-step Warming Protocol for Blastocyst FET · NA · recruiting
- NCT06544837 — Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation · NA · recruiting
- NCT06334003 — Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology · recruiting
- NCT06577181 — Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer · active not recruiting
Other Stochastic Research Technologies LLC trials
Trials by the same sponsor.
- NCT05811065 — Decision Support Tool for Gonadotrophin Dose Selection in ART. · NA · completed
- NCT05564702 — An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice · NA · completed
- NCT05377879 — An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05981898 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stochastic Research Technologies LLC
- Last refreshed: 17 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05981898.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing